Novozymes A/S (OTCMKTS:NVZMY) Share Price Crosses Below Fifty Day Moving Average – What’s Next?

Novozymes A/S (OTCMKTS:NVZMY)’s share price passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $60.70 and traded as low as $56.00. Novozymes A/S shares last traded at $56.00, with a volume of 17,470 shares.

Analyst Upgrades and Downgrades

NVZMY has been the topic of a number of recent analyst reports. Berenberg Bank upgraded shares of Novozymes A/S to a “strong-buy” rating in a report on Tuesday, September 24th. Barclays upgraded shares of Novozymes A/S to a “strong-buy” rating in a research note on Monday, November 18th. Finally, Citigroup downgraded shares of Novozymes A/S from a “neutral” rating to a “sell” rating in a research note on Thursday, October 17th.

Novozymes A/S Trading Down 0.6 %

The business has a 50 day moving average of $60.70 and a two-hundred day moving average of $63.36. The firm has a market cap of $26.22 billion, a P/E ratio of 35.44, a PEG ratio of 3.87 and a beta of 0.87.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.